Dr Christine D Rogness, MD | |
9399 Crown Crest Blvd, Suite 220, Parker, CO 80138-8506 | |
(303) 805-1855 | |
(303) 805-4421 |
Full Name | Dr Christine D Rogness |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 33 Years |
Location | 9399 Crown Crest Blvd, Parker, Colorado |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1790892008 | NPI | - | NPPES |
64475565 | Medicaid | CO | |
01351246 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 35124 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Parker Adventist Hospital | Parker, CO | Hospital |
Castle Rock Adventist Hospital | Castle rock, CO | Hospital |
St. Anthony Summit Medical Center | Frisco, CO | Hospital |
Aurora South Hospital And Medical Center | Aurora, CO | Hospital |
Entity Name | Chris B Winter Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821181876 PECOS PAC ID: 3870588601 Enrollment ID: O20040420000064 |
News Archive
Welders who are exposed to manganese from welding fumes, risk developing increased clumsiness - and the result may remain decades after exposure has ceased. This is the finding of a study at the University of Gothenburg, Sweden, of former shipyard workers.
The University of Chicago has received certification from the Gluten Intolerance Group's Gluten-Free Food Service (GFFS) Accreditation Program for its medical center and campus food service operations. The designation makes UChicago one of three medical centers in the United States to carry the accreditation, and the only academic institution to do so for both its hospital and campus facilities.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
› Verified 9 days ago
Entity Name | Colorado Surgical And Critical Care Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295846426 PECOS PAC ID: 7810978095 Enrollment ID: O20040525000664 |
News Archive
Welders who are exposed to manganese from welding fumes, risk developing increased clumsiness - and the result may remain decades after exposure has ceased. This is the finding of a study at the University of Gothenburg, Sweden, of former shipyard workers.
The University of Chicago has received certification from the Gluten Intolerance Group's Gluten-Free Food Service (GFFS) Accreditation Program for its medical center and campus food service operations. The designation makes UChicago one of three medical centers in the United States to carry the accreditation, and the only academic institution to do so for both its hospital and campus facilities.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
› Verified 9 days ago
Entity Name | Mountain View Surgical Associates-summit Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356825848 PECOS PAC ID: 5890027395 Enrollment ID: O20191104000703 |
News Archive
Welders who are exposed to manganese from welding fumes, risk developing increased clumsiness - and the result may remain decades after exposure has ceased. This is the finding of a study at the University of Gothenburg, Sweden, of former shipyard workers.
The University of Chicago has received certification from the Gluten Intolerance Group's Gluten-Free Food Service (GFFS) Accreditation Program for its medical center and campus food service operations. The designation makes UChicago one of three medical centers in the United States to carry the accreditation, and the only academic institution to do so for both its hospital and campus facilities.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christine D Rogness, MD 9399 Crown Crest Blvd, Suite 220, Parker, CO 80138-8506 Ph: (303) 805-1855 | Dr Christine D Rogness, MD 9399 Crown Crest Blvd, Suite 220, Parker, CO 80138-8506 Ph: (303) 805-1855 |
News Archive
Welders who are exposed to manganese from welding fumes, risk developing increased clumsiness - and the result may remain decades after exposure has ceased. This is the finding of a study at the University of Gothenburg, Sweden, of former shipyard workers.
The University of Chicago has received certification from the Gluten Intolerance Group's Gluten-Free Food Service (GFFS) Accreditation Program for its medical center and campus food service operations. The designation makes UChicago one of three medical centers in the United States to carry the accreditation, and the only academic institution to do so for both its hospital and campus facilities.
OriGene Technologies, Inc., a leading gene-centric life sciences company, announced the completion of a $16 million Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO. OriGene's previous investors Morningside Venture Investments and President International Development Corp. (PIDC) also participated in this round. The proceeds from the funding will be used to continue to build OriGene's TrueMAB™ monoclonal antibody collection.
Sanofi-aventis announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease progressed following treatment with docetaxel-based chemotherapy.
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule does not adequately protect the privacy of people's personal health information and hinders important health research discoveries, concludes a new report from the Institute of Medicine.
› Verified 9 days ago
John H Sun, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9397 Crown Crest Blvd, Suite 201, Parker, CO 80138 Phone: 303-320-0699 Fax: 303-320-0897 | |
Wanda Marie Good, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9399 Crown Crest Blvd Ste 220, Parker, CO 80138 Phone: 303-805-1855 Fax: 303-805-4421 | |
Dr. Stephen M Barnes, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9397 Crown Crest Blvd, Suite 210, Parker, CO 80138 Phone: 303-805-9802 Fax: 303-805-9008 | |
Dr. Gordon Nordell Olinger, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 5108 Horned Owl Way, Parker, CO 80134 Phone: 303-284-9855 Fax: 303-284-9855 | |
Dr. Jeffrey Nolan Harr, M.D., M.P.H Surgery Medicare: Accepting Medicare Assignments Practice Location: 9399 Crown Crest Blvd Ste 220, Parker, CO 80138 Phone: 303-805-1855 Fax: 303-805-4421 | |
Dr. Blake Dewayne Babcock, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9399 Crown Crest Blvd Ste 220, Parker, CO 80138 Phone: 303-805-1855 Fax: 303-805-4421 | |
Dr. David Michael Hardin, MD Surgery Medicare: Medicare Enrolled Practice Location: 9399 Crown Crest Blvd, Suite 430, Parker, CO 80138 Phone: 303-269-2310 Fax: 904-446-3013 |